Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure

Oncology. 2007;72(3-4):209-10. doi: 10.1159/000112828. Epub 2007 Dec 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Bevacizumab
  • Cetuximab
  • Colorectal Neoplasms / complications
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / secondary
  • Colorectal Neoplasms / surgery
  • Feasibility Studies
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Renal Dialysis
  • Renal Insufficiency / complications*
  • Renal Insufficiency / therapy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab
  • Cetuximab